Cargando…
The activation of mTOR signalling modulates DNA methylation by enhancing DNMT1 translation in hepatocellular carcinoma
BACKGROUND: Both dysregulation of mechanistic target of rapamycin (mTOR) signalling and DNA methylation patterns have been shown to be closely associated with tumor progression and serve as promising targets for hepatocellular carcinoma (HCC) therapy. Although their respective roles in HCC have been...
Autores principales: | Chen, Mengke, Fang, Yi, Liang, Meinong, Zhang, Ning, Zhang, Xinyue, Xu, Lixia, Ren, Xuxin, Zhang, Qingfeng, Zhou, Yufeng, Peng, Sui, Yu, Jun, Zeng, Judeng, Li, Xiaoxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124003/ https://www.ncbi.nlm.nih.gov/pubmed/37088830 http://dx.doi.org/10.1186/s12967-023-04103-9 |
Ejemplares similares
-
FGF14 Functions as a Tumor Suppressor through Inhibiting PI3K/AKT/mTOR Pathway in Colorectal Cancer
por: Su, Tianhong, et al.
Publicado: (2020) -
RNF135 Promoter Methylation Is Associated With Immune Infiltration and Prognosis in Hepatocellular Carcinoma
por: Wang, Xiao, et al.
Publicado: (2022) -
The Translational Regulation in mTOR Pathway
por: Yang, Miaomiao, et al.
Publicado: (2022) -
mTOR Signaling, Translational Control, and the Circadian Clock
por: Cao, Ruifeng
Publicado: (2018) -
FUS contributes to mTOR-dependent inhibition of translation
por: Sévigny, Myriam, et al.
Publicado: (2021)